Houston Matters

Houston Methodist Studying Effects of Emerging Immunotherapy Drug

Posted on · A study underway at Methodist Hospital compares the effects of an immunotherapy drug to a chemotherapy drug on certain lung cancer development. Lung cancer is the second most common malignancy in the United States. We learn more about the study from its principal investigator, Dr. Eric Bernicker, Thoracic Medical Oncologist with the Houston Methodist Cancer Center.

Houston Matters

What a Sea Snail Can Teach Us About the Side Effects of Chemotherapy

Posted on · Cancer patients who undergo chemotherapy are familiar with potential side effects, including what’s commonly known as “chemo brain” – some struggle to concentrate, or have memory problems during a course of chemotherapy. There are treatments to mitigate such effects, but mostly, patients just have to live with it until their treatment is over. A new study here […]

Full Show

High Speed Rail, Chemo Brain, and Tomato Republic: Houston Matters for Wednesday, Oct. 29, 2014

Posted on · What’s the secret to community buy-in for a high-speed rail project? Location, location, location. Last spring, we spoke with former Harris County judge and Texas Central Railway President Robert Eckels about his company’s effort to construct a privately funded bullet train between Houston and Dallas/Fort Worth. Texas Central Railway first proposed the plan to build the rail […]